Evaluation of COVID-19 vaccination strategies with a delayed second dose

Mostrar otras versiones (1)

Two of the COVID-19 vaccines currently approved in the United States require two doses, administered three to four weeks apart. Constraints in vaccine supply and distribution capacity, together with a deadly wave of COVID-19 from November 2020 to January 2021 and the emergence of highly contagious S...

Descripción completa

Detalles Bibliográficos
Autores principales: Moghadas, Seyed M., Vilches, Thomas N., Zhang, Kevin, Nourbakhsh, Shokoofeh, Sah, Pratha, Fitzpatrick, Meagan C., Galvani, Alison P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7852256/
https://www.ncbi.nlm.nih.gov/pubmed/33532805
http://dx.doi.org/10.1101/2021.01.27.21250619

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7852256/
https://www.ncbi.nlm.nih.gov/pubmed/33532805
http://dx.doi.org/10.1101/2021.01.27.21250619

Ejemplares similares